Adeshwar Meditex Ltd vs Ccme Global Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Adeshwar Meditex Ltd is ₹ 18.75 as of 23 Oct 15:30 . The P/E Ratio of Adeshwar Meditex Ltd changed from 49.9 on March 2022 to 19.3 on March 2026 . This represents a CAGR of -17.30% over 5 yearsThe P/E Ratio of CCME Global Ltd changed from 6.8 on March 2025 to 0 on March 2026 . This represents a CAGR of -100.00% over 2 years The Market Cap of Adeshwar Meditex Ltd changed from ₹ 39.61 crore on March 2022 to ₹ 24.5 crore on March 2026 . This represents a CAGR of -9.16% over 5 yearsThe Market Cap of CCME Global Ltd changed from ₹ 12.13 crore on March 2022 to ₹ 447.88 crore on March 2026 . This represents a CAGR of 105.81% over 5 years The revenue of Adeshwar Meditex Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of CCME Global Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0.04 crore. This represent the decline of -100% The ebitda of Adeshwar Meditex Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of CCME Global Ltd for the Jun '26 is ₹ -0.24 crore as compare to the Mar '26 ebitda of ₹ -0.5 crore. This represent the decline of -52% The net profit of Adeshwar Meditex Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of CCME Global Ltd changed from ₹ -0.1 crore to ₹ -0.26 crore over 9 quarters. This represents a CAGR of 52.91% The Dividend Payout of Adeshwar Meditex Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of CCME Global Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Adeshwar Meditex Ltd

Adeshwar Meditex Limited was incorporated as private limited Company on April 02, 2007 and later on was converted into a Public Limited Company on March 09, 202'.
The Company is a leading manufacturer and exporter of sterile surgical wound dressings and medical disposables. The Company is established to carry on business of manufacturers and exporters of all forms of first aid kits, surgical dressing, surgical plastics and other medical disposables.
The Company is operating in the business of manufacturers, producers, refiners, processors, exporters, importers, distributors, traders, merchants, dealers, representatives. selling agents, buying agents, re-packers, buyers, sellers, wholesalers, retailers, suppliers and stockiest of all kinds and varieties of surgical, pharmaceutical, medicine items including first aid kits in various sizes for hospitals, medical centers, households, schools and various industries including automobile sector, surgical dressings including sterile medicated wound dressings, sterile advanced hemostatic dressings, chitosan, oxidized cellulose and gelatin sponges, medical bandages including elastic, adhesive and non-adhesive, adhesive tapes and plasters including medicated and non-medicated, military dressings for defense services, sterile gauzes, dressings, swabs including medicated and non-medicated, orthopedic bandages, dressings, orthopedic soft products and equipment, sanitary napkins, surgical gloves, surgical blades, infusion sets and allied products, antiseptic solutions, disinfectants, hand sanitizers, ointments including medicated and non-medicated, rectified spirit, extra neutral ethyl alcohol, and alcohol based products, sterile pre and post operations medical kits, home-based new born (HBNC) and other kits, face masks, caps, gowns, face shield, PPE kits, HIV kits, all hospital protective wears and disposables, laboratory reagents, testing kits and dealing in various items and Turnkey projects for all of the above products and other ancillary business.

About CCME Global Ltd

Genesis IBRC India Limited was formerly incorporated as Fine Plast Polymers Limited in October, 1992.
Thereafter, the name of the Company was changed from Fine Plast Polymers Limited to SSK Lifestyles Limited in October, 2014 and further was changed from SSK Lifestyles Limited to Genesis IBRC India Limited in January, 2018.
Promoted by P M Rao, P Janardhana Rao, P Rama Rao and their Associates, the Company came out with a public issue in Dec.'93 to part-finance the setting up of its plant in Pamur, Andhra Pradesh.
The plant has an installed capacity of 432 tpa for rigid PVC pipes and 778 tpa for PVC fittings. Initially, Company manufactured rigid PVC pipes and fittings like tees, elbows, adopters, reducers, end caps, etc. used in agriculture and agro-based activities like sprinkler irrigation systems, process piping, oil and gas and shipping industries.

FAQs for the comparison of Adeshwar Meditex Ltd and CCME Global Ltd

Which company has a larger market capitalization, Adeshwar Meditex Ltd or CCME Global Ltd?

Market cap of Adeshwar Meditex Ltd is 27 Cr while Market cap of CCME Global Ltd is 136 Cr

What are the key factors driving the stock performance of Adeshwar Meditex Ltd and CCME Global Ltd?

The stock performance of Adeshwar Meditex Ltd and CCME Global Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Adeshwar Meditex Ltd and CCME Global Ltd?

As of October 25, 2026, the Adeshwar Meditex Ltd stock price is INR ₹18.75. On the other hand, CCME Global Ltd stock price is INR ₹30.22.

How do dividend payouts of Adeshwar Meditex Ltd and CCME Global Ltd compare?

To compare the dividend payouts of Adeshwar Meditex Ltd and CCME Global Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.